ISSN: 1750-743X
Journal Home
Journal Guideline
Immunotherapy Q2 Unclaimed
Immunotherapy is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 65. It has an SJR impact factor of 0,69 and it has a best quartile of Q2. It has an SJR impact factor of 0,69.
Immunotherapy focuses its scope in these topics and keywords: immunotherapy, model, immune, cells, cell, t, adoptive, fate, fab’neutralize, expressing, ...
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,69
SJR Impact factor65
H Index141
Total Docs (Last Year)419
Total Docs (3 years)6537
Total Refs1015
Total Cites (3 years)398
Citable Docs (3 years)2.46
Cites/Doc (2 years)46.36
Ref/DocOther journals with similar parameters
Clinical and Experimental Allergy Q2
Expert Review of Clinical Immunology Q2
Immunology and Cell Biology Q2
International Reviews of Immunology Q2
Clinical and Experimental Immunology Q2
Compare this journals
Aims and Scope
Best articles by citations
Melanoma: a prototype of cancer-testis antigen-expressing malignancies
View morePentapeptide commonality betweenCorynebacterium diphtheriaetoxin and theHomo sapiensproteome
View moreModulation of cancer-specific immune responses by amino acid degrading enzymes
View moreBiologics in spondyloarthritis: TNFa inhibitors and other agents
View moreEpstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?
View moreAdjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV-coinfected TB
View moreBapineuzumab: anti-beta-amyloid monoclonal antibodies for the treatment of Alzheimer's disease
View moreResearch Highlights
View moreAnti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis
View moreTargeting targeted therapies
View moregammad T cell-based anticancer immunotherapy: progress and possibilities
View moreDoes clinical protection persist after food allergen oral immunotherapy?
View moreInvariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens
View moreResearch Highlights: Immunotherapy to overcome lung tumor cell-induced escape from immunosurveillance
View moreStrategies to improve BCG vaccine efficacy
View moreCould targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure?
View moreCarboplatin hypersensitivity: evaluation and successful desensitization protocol
View moreCould targeting T-helper cells aid the development of effective cancer vaccines?
View morePalmoplantar pustular psoriasis induced by adalimumab: a case report and literature review
View moreCryptococcus neoformansgalactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy
View moreProduction of anti-CD3/28 expanded CD4+ T lymphocytes from HIV-infected patients with different degrees of disease progression
View moreScancell's vaccine SCIB1 could help to prevent recurrence of melanoma
View moreDevelopment of a new tuberculosis vaccine: is there value in the mucosal approach?
View moreA Phase I clinical trial with subcutaneous immunotherapy vaccine of Timothy grass pollen extract according to EMA guidelines
View more
Comments